Paris, France

Pascal Pigeon

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Paris Sciences Et Lettres-Quartier Latin. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pascal Pigeon. Retrieved from https://idiyas.com/inventor/pascal-pigeon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Pascal Pigeon

Introduction

Pascal Pigeon is a notable inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential anticancer properties. His work exemplifies the intersection of scientific research and practical application in the medical field.

Latest Patents

Pascal Pigeon holds a patent for "Metallocene derivatives with anticancer activity." This invention relates to a compound of a specific formula or a pharmaceutically acceptable salt or solvate thereof. It also includes a stereoisomer or a mixture of stereoisomers in any ratio, or a water-soluble derivative. The patent outlines methods for preparing these compounds and their use, particularly in the treatment of cancer.

Career Highlights

Pascal Pigeon is affiliated with Paris Sciences et Lettres-Quartier Latin, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to advancing medical science.

Collaborations

Pascal has collaborated with esteemed colleagues such as Siden Top and Gerard Jaouen. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving innovative breakthroughs.

Conclusion

Pascal Pigeon is a distinguished inventor whose work in developing metallocene derivatives demonstrates the potential for innovation in cancer treatment. His contributions to medicinal chemistry are noteworthy and reflect a commitment to improving health outcomes through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…